Amundi
EW icon

Amundi’s Edwards Lifesciences EW Stock Holding History

Amundi’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214M Buy
2,670,209
+12,171
+0.5% +$1M 0.06% 270
2025
Q4 		$227M Buy
2,658,038
+5,076
+0.2% +$417K 0.06% 310
2025
Q3 		$203M Sell
2,652,962
-808,167
-23% -$63.1M 0.07% 263
2025
Q2 		$267M Buy
3,461,129
+541,943
+19% +$40.4M 0.09% 208
2025
Q1 		$213M Sell
2,919,186
-402,011
-12% -$28.8M 0.08% 247
2024
Q4 		$246M Sell
3,321,197
-161,211
-5% -$11.3M 0.09% 227
2024
Q3 		$239M Sell
3,482,408
-1,735,109
-33% -$126M 0.09% 219
2024
Q2 		$476M Sell
5,217,517
-302,340
-5% -$26.8M 0.18% 122
2024
Q1 		$480M Sell
5,519,857
-710,696
-11% -$59.7M 0.21% 114
2023
Q4 		$473M Buy
6,230,553
+318,902
+5% +$22.2M 0.21% 118
2023
Q3 		$418M Sell
5,911,651
-1,498,503
-20% -$120M 0.21% 116
2023
Q2 		$679M Buy
7,410,154
+914,993
+14% +$79.5M 0.34% 60
2023
Q1 		$542M Sell
6,495,161
-1,613,687
-20% -$127M 0.29% 82
2022
Q4 		$629M Buy
8,108,848
+1,673,580
+26% +$129M 0.35% 66
2022
Q3 		$561M Buy
6,435,268
+1,154,632
+22% +$111M 0.33% 61
2022
Q2 		$511M Sell
5,280,636
-47,911
-0.9% -$4.96M 0.41% 50
2022
Q1 		$658M Buy
5,328,547
+881,088
+20% +$98.8M 0.45% 42
2021
Q4 		$538M Sell
4,447,459
-351,962
-7% -$41.1M 0.34% 68
2021
Q3 		$543M Buy
4,799,421
+29,607
+0.6% +$3.38M 0.38% 56
2021
Q2 		$494M Buy
+4,769,814
New +$450M 0.34% 61

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Amundi's EW Position: Q1 2026 in Review

Amundi increased its Edwards Lifesciences (EW) stake by 0.46% in Q1 2026, buying an estimated $1M and bringing the position to 2,670,209 shares worth $214M. The position accounts for 0.06% of the portfolio, ranked #270.

Amundi first reported a position in EW in Q2 2021 and has held it in 20 quarters since. The position peaked at $679M in Q2 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Amundi held 2,670,209 shares of Edwards Lifesciences worth $214M as of Q1 2026.
  • Amundi bought 12,171 Edwards Lifesciences shares in Q1 2026, an estimated $1M.
  • Edwards Lifesciences made up 0.06% of Amundi's portfolio in Q1 2026, its #270 holding.
  • Amundi first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Edwards Lifesciences position peaked at $679M in Q2 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.